3RD ANNUAL CHEP+ CONFERENCE

Clinical Practice Guidelines Update
Managing the Multi-Comorbid Patient
Bringing the Guidelines Together - Online (LIVE)
Saturday, March 27, 2021

8:45 AM - 3:15 PM (ET)*

Registration: $125

* * REGISTER NOW * *

We are pleased to host the third annual “CHEP+” Conference forupdated C-CHANGE Clinical Practice Guidelines. This interactiveand practical program is designed for family physicians, specialists,nurse practitioners, nurses, pharmacists and other primary carepractitioners with an interest in cardiovascular disease preventionand management.

View Full Program

REGISTRATION  & ACCREDITATION

 

Saturday March 27, 2021

8:45 AM - 3:15 PM (ET)*

*Note: Eastern time zone. This is an online (live), virtual conference.  The conference will be recorded, and will be available to registrants for viewing.

 

Accreditation:

The College of Family Physicians of Canada 9.0 Mainpro+ Credits - (and additional TBC)

Royal College of Physicians and Surgeons of Canada - TBC

This year’s conference is devoted to updates from Diabetes, Obesity, and Cardiac Rehabilitation and the latest clinical trial results and challenges facing the care of multi-morbidity patients with complex conditions with a focus on heart failure.


Plenary Talks from Guideline Leads
• Diabetes guideline update
• Obesity guideline update
• Lipid guideline update
• Newest recommendations for cardiac rehabilitation
• Latest Stroke Best Practice Guideline
• Guideline on prescribing physical activity
• Kidney disease management and prevention


CO-CHAIRS:
Rahul Jain, MD and Sheldon Tobe, MD
Clinical Practice Guidelines Update

Workshop Speakers/Facilitators:
 

Richard Choi, MD, FRCPC
Dr. Choi is a staff cardiologist at St. Joseph's Health Centre/ Unity Health Toronto and clinical adjunct faculty/Lecturer in the Department of Medicine at the University of Toronto.

Lisa Dubrofsky, MDCM, FRCPC, FASH
Dr. Dubrofsky is a Clinical Associate, Division of Nephrology, Sunnybrook Health Sciences Centre

Benedict M Glover, MD, MRCP
Dr. Glover is a staff cardiologist at Sunnybrook Health Sciences Centre with a specific interest in atrial fibrillation and ventricular arrhythmias, catheter ablation and device therapy.

 

Jeff Habert MD, CCFP, FCFP
Dr. Habert is an Assistant Professor in the Department of Family and Community Medicine at the University of Toronto, Co-Chair of Clinical Guidelines Committee Thrombosis Canada.

 

Rahul Jain, MD, CCFP, MScCH (HPTE)
Dr. Jain is a Family Physician and Hospitalist, Sunnybrook Health Sciences Centre Assistant Professor, University of Toronto, Department of Family and Community Medicine.

 

Sol Stern, MD, MSc, MCFP
Dr. Stern is a Family Physician at Argus Medical Centre in Oakville, Ontario.

 

Sheldon Tobe, MD, FRCPC, MScCH (HPTE), FACP, FAHA
Dr. Tobe is a specialist in Hypertension and Nephrology, Division of Nephrology, Sunnybrook Health Sciences Centre, and is the University of Toronto Postgraduate Fellowship
Director – Nephrology. He is a Professor in the Faculty of Medicine, University of Toronto and Northern Ontario School of Medicine.

 

Jonathan Gabor, MSc, MD, FRCPC, SCH, Dip. ABOM Department of Medicine, Concordia General Hospital, Winnipeg, Manitoba

PLENARY SPEAKERS

Stroke Best Practice Guidelines
Alexandre Y. Poppe, MD, CM, FRCPC
Clinical Associate Professor, Department of Neurosciences, Université de Montréal
Stroke Neurologist, Stroke fellowship program director Centre Hospitalier de l’Université de Montréal (CHUM)

 

Diabetes Canada Guidelines

Peter Senior, MBBS, PhD
Professor of Medicine, Director, Division of Endocrinology and Metabolism, University of Alberta Clinical Section Head, Endocrinology and Metabolism, Alberta Health Services Medical Director, Clinical Islet Transplant Program, Alberta Health Services Co-director, Northern Alberta Diabetic Nephropathy Prevention Program

 

Obesity Canada Guidelines

Sean Wharton, MD, DPharm
Women’s College Hospital, Hamilton Health Sciences Centre
Assistant Clinical Professor, McMaster University Canadian Association of

 

Cardiovascular Prevention and Rehabilitation (CACPR) Guidelines

Simon Bacon, PhD, FTOS, FCCS, FABMR Co-Director, Montreal Behavioural Medicine Centre
CIUSSS-NIM, Hopital du Sacre-Coeur de Montreal Professor, Department of Health, Kinesiology, and Applied
Physiology, Concordia University

 

Canadian Cardiovascular Society – Dyslipidemia Guidelines

Glen J. Pearson, BScPhm, PharmD, FCSHP, FCCS
Professor of Medicine, Co-Director, Cardiac Transplant Clinic Chair,
Trainee Research Access Committee (TRAC) University of Alberta, Division of Cardiology Mazankowski Alberta Heart Institute

-----

AGENDA

8:45 – 9:00 Introductions • C-CHANGE Update 2021
• Orientation and Certification - Dr. Rahul Jain,  Diane Hua-Stewart

9:00 – 11:45 Plenary - Dr. Sheldon Tobe

9:00 – 9:20 Plenary 1 What’s New in Stroke Best Practices? Dr. Alexandre Poppe

9:20 – 9:40 Plenary 2 What’s New in Diabetes? Dr. Peter Senior

9:40 – 10:00 Plenary 3 What’s New in Obesity? Dr. Sean Wharton

10:00 – 10:30 Q&A, Exhibitor Showcase

10:30 – 10:50 Plenary 4 What’s New in Cardiac Rehab? Dr. Simon Bacon

10:50 – 11:10 Plenary 5 What’s New in Lipids (CCS)? Dr. Glen Pearson

11:10 – 12:00 Q&A, Exhibitor Showcase, Sponsored Satellite Symposium TBD


12:00 – 13:00 Session A Concurrent Workshops
A1: CV Risk Reduction in T2DM - SGLT2i/GLP1 in Patients with DM and CVD Dr. Sol Stern
A2: Cardiovascular Management of Patients with Chronic Kidney Disease Dr. Sheldon Tobe
A3: Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease Dr. Benedict Glover

13:00 – 14:00 Session B Concurrent Workshops

B1: How C-CHANGE can Help Management of the multi co-morbidity patient Dr. Rahul Jain
B2: Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease Dr. Jeffrey Haber
B3: Blood Pressure Measurement Diagnosis and Follow-Up of Hypertension Dr. Lisa Dubrofsk

14:00 – 15:00 Session C Concurrent Workshops
C1: Renal Protection in Patients with Diabetes and Advanced Nephropathy Dr. Sheldon Tobe
C2: ARNI in Reduced Ejection Fraction Heart Failure (HFrEF) Dr. Richard Choi
C3: Blood Pressure Measurement Diagnosis and Follow-Up of Hypertension Dr. Jonathan Gabor
15:00 – 15:15 Closing Remarks – Evaluation

-------

Concurrent Workshops

 

Format: The sessions are led by a trained facilitator. Sessions are 60 min case-based interactive group workshops (40 min of presentation with discussion questions to stimulate discussion of case presentation, labs, history, practice and data points, and
20 min for topic related Q & A throughout the case module)

 

Blood Pressure Measurement Diagnosis and Follow-Up of Hypertension
Upon completion of this case study, participants should be able to:
• To describe the new Hypertension Canada recommendations and algorithm for the diagnosis of hypertension
• To outline the rationale for and the methods for using automated office blood pressure measurements.
• Define White Coat Hypertension, Masked Hypertension, and Masked Uncontrolled Hypertension (MUCH)
• To describe tools for helping learners acquire and teach the knowledge and skills for blood pressure measurement.

 

How C-CHANGE can Help Management of the multi co-morbidity patient
Upon completion of this activity, participants will be able to:
• Identify recommendations for multiple morbidities from the C-CHANGE guidelines
• Implement recommendations for multiple morbidities in a single patient
• Use the C-CHANGE recommendations to help keep the elderly living at home longer and healthier

Cardiovascular Management of Patients with Chronic Kidney Disease
Upon completion of this activity, participants should be able to:
• Identify a patient with chronic kidney disease.
• Formulate a treatment plan for renal and cardiovascular risk reduction using the C-CHANGE guidelines including BP control
and lipid management and SGLT2i.
• Communicate and initiate the treatment plan to reduce renal and cardiovascular risk in patients with chronic kidney disease

 

CV Risk Reduction in Diabetes (SGLT2 inhibitors/GLP-1 Receptor Agonists in Patients with DM and CVD)
Upon completion of this case study, participants should be able to:
• Describe the patient who should be treated with an SGLT2i or GLP-1 RA
• Explain the rational for this treatment and the potential benefits
• Describe the steps for initiating and monitoring therapy for patients with diabetes

 

Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease
Upon completion of this activity, participants should be able to:
• Describe the rational for anticoagulation of non-valvular atrial fibrillation
• Describe the effect on outcomes of non-valvular atrial fibrillation with CKD
• Describe the management of patients with CKD and non-valvular atrial fibrillation

 

ARNI in Reduced Ejection Fraction Heart Failure (HFrEF)
Upon completion of this activity, participants should be able to:
• Describe the epidemiology and pathophysiology of reduced ejection fraction heart failure (HFrEF) and preserved ejection
fraction heart failure (HFpEF)
• Describe the current management of HFrEF
• Describe the evidence for ARNI in HFrEF
• Apply the clinical practice guideline for ARNI in HFrEF

 

Renal Protection in Patients with Diabetes and Advanced Nephropathy
Upon completion of this activity, participants should be able to:
• Describe advanced diabetic nephropathy and its consequences
• Explain the rationale for the management of advanced nephropathy and the potential benefits
• Describe how advanced nephropathy might be prevented

REGISTER TODAY

CONTACT US:

For more info about this event or upcoming CHEP Plus workshops:  diane@chepplus.com

Subscribe Form

  • Facebook
  • Twitter
  • LinkedIn

©2020 by CHEP Plus. Proudly created with Wix.com